Another Gene Increasing Breast Cancer Susceptibility Identified: PALB2

A study published in the August 2014 issue of the prestigious New England Journal of Medicine found that mutations in a gene called PALB2 increase breast cancer susceptibility, in addition to BRCA1 and BRCA2.
Breast cancer is a serious disease caused by uncontrolled or abnormal growth and multiplication of cells in breast tissue and is the most common cancer among women. The lifetime risk of developing this cancer is one in every 8 women. Preventing it before it develops is therefore the highest priority. Effective prevention first requires identifying factors that cause the disease and/or increase susceptibility. Many environmental factors contributing to breast and other cancers have been identified. Certain inherited factors and alterations in genes are also known to contribute, but very few of these genes have been identified. Identifying them is crucial for prevention or early diagnosis of the associated cancers. If susceptibility genes are identified, tests can determine in advance who is predisposed to cancer, allowing a potential cancer to be prevented.
There are 2 genes known to contribute to breast cancer development and susceptibility: BRCA1 and BRAC2. Women known or suspected to carry BRCA1 or BRCA2 mutations have a high risk of breast cancer. BRCA1 and BRCA2 genes help repair damage to cellular DNA. Damage to BRCA1 or BRCA2 impairs DNA repair and increases breast cancer risk. These altered genes are also passed from parents to children across generations. Relatives of someone carrying an altered gene may therefore carry it as well and have a high breast cancer risk. People with first-degree relatives who have breast and/or ovarian cancer, which is also associated with BRCA, should consequently be investigated for an alteration in this gene; those with an alteration need monitoring and breast cancer screening. Many cancers can be prevented before developing in this way. A recently published study involving 14 scientists from 8 countries found that PALB2 is also associated with breast cancer susceptibility.
The study examined data from 362 individuals in 154 families with PALB2 mutations and found a higher risk of breast cancer. Among women with the mutation, risk was 8 times higher below age 40, 6-8 times higher at ages 40-60, and 5 times higher above age 60. Overall, mutation carriers had a 14% risk of developing breast cancer by age 50 and a 35% risk by age 70. Risk was 33% among carriers without a family history of breast cancer, rising to 58% in those with at least 2 first-degree relatives with breast cancer.
In conclusion, identifying another gene associated with breast cancer susceptibility in addition to BRCA is a major advance for prevention and early diagnosis. Although the scientific evidence is not yet mature enough to put these findings into clinical practice, PALB2 has joined the potential genes that may be screened in people with a family history of breast cancer in the future.
Sources
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.